P

PBYI

PBYI

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
PBYI Live QuoteReal-time
$7.12
$3.78(-34.68%)1M
Day Range$7.06 – $7.30
Open$7.21
Previous Close$7.22
Volume469.4K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$373.26M
P/E Ratio (TTM)15.7
Forward P/E3.5
EPS (TTM)$0.46
Price to Book2.5
Dividend Yield0.65%
Beta (Volatility)1.33
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $7.12 (34%)
Low: $4.83High: $11.50
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$6.00-96.0% upside

Insider Buys

0

$0

Insider Sales

29

$3.06M

Total Volume

$3.06M

38 transactions

Net Activity

$3.06M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
25CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
A
1

Auerbach Alan H

Pres, CEO, 10%

0 buys4 sells

$842K total

C
2

Cesano Alessandra

Dir

0 buys3 sells

$699K total

S
3

Senderowicz Adrian

Dir

0 buys2 sells

$286K total

M
4

Moyes Jay M

Dir

0 buys2 sells

$234K total

M
5

Miller Michael Patrick

Dir

0 buys2 sells

$219K total

Trading History
PBYI insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 11, 2026

1 weeks ago

Miller Michael Patrick

Dir

Director
Sell15.0K$8.10$121K

Sep 14, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell55.3K$-5000.00$0

Sep 14, 2026

2 months ago

Wilson Troy Edward

Dir

Director
Sell5.0K$9.10$46K

Sep 14, 2026

2 months ago

Cesano Alessandra

Dir

Director
Sell62.1K$9.12$567K

Jul 6, 2026

4 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell7.26M$-44058.00$0

Jul 6, 2026

4 months ago

Auerbach Alan H

Pres, CEO, 10%

CEO
Sell44.1K$8.26$364K

Jul 6, 2026

4 months ago

Hunt Douglas M

See Remarks

Insider
Sell8.5K$8.26$70K

Jul 6, 2026

4 months ago

Nougues Maximo F

CFO

CFO
Sell9.4K$8.26$78K

Jun 12, 2026

5 months ago

Senderowicz Adrian

Dir

Director
Sell27.0K$7.20$194K

Jun 12, 2026

5 months ago

Wilson Troy Edward

Dir

Director
Sell10.8K$7.20$78K

Jun 12, 2026

5 months ago

Stuglik Brian M

Dir

Director
Sell8.1K$7.20$58K

Jun 12, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell60.3K$-10800.00$0

Jun 12, 2026

5 months ago

Dorval Allison

Dir

Director
Sell11.6K$7.20$84K

Jun 12, 2026

5 months ago

Moyes Jay M

Dir

Director
Sell22.0K$7.22$159K

Jan 6, 2026

10 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell7.15M$-34950.00$0

Jan 6, 2026

10 months ago

Auerbach Alan H

Pres, CEO, 10%

CEO
Sell35.0K$5.86$205K

Jan 6, 2026

10 months ago

Hunt Douglas M

See Remarks

Insider
Sell9.0K$5.86$53K

Jan 6, 2026

10 months ago

Nougues Maximo F

CFO

CFO
Sell10.9K$5.86$64K

Nov 11, 2025

12 months ago

Miller Michael Patrick

Dir

Director
Sell20.0K$4.86$97K

Nov 11, 2025

12 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell54.0K$-20000.00$0

Jul 18, 2025

16 months ago

Cesano Alessandra

Dir

Director
Sell27.0K$3.37$91K

Jul 18, 2025

16 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell41.9K$-27000.00$0

Jul 8, 2025

16 months ago

Hunt Douglas M

See Remarks

Insider
Sell7.8K$3.53$28K

Jul 8, 2025

16 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell204.2K$-9522.00$0

Jul 8, 2025

16 months ago

Nougues Maximo F

CFO

CFO
Sell9.5K$3.53$34K

Jul 8, 2025

16 months ago

Auerbach Alan H

Pres, CEO, 10%

CEO
Sell47.2K$3.53$167K

Jun 13, 2025

17 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell44.1K$-10800.00$0

Jun 13, 2025

17 months ago

Wilson Troy Edward

Dir

Director
Sell10.8K$3.40$37K

Jun 13, 2025

17 months ago

Stuglik Brian M

Dir

Director
Sell8.1K$3.39$27K

Jun 13, 2025

17 months ago

Senderowicz Adrian

Dir

Director
Sell27.0K$3.40$92K

Jun 13, 2025

17 months ago

Moyes Jay M

Dir

Director
Sell22.0K$3.40$75K

Jun 13, 2025

17 months ago

Dorval Allison

Dir

Director
Sell11.6K$3.40$39K

Jun 13, 2025

17 months ago

Cesano Alessandra

Dir

Director
Sell12.2K$3.40$41K

Jan 2, 2025

22 months ago

Nougues Maximo F

CFO

CFO
Sell10.2K$3.15$32K

Jan 2, 2025

22 months ago

Ludwig Jeffrey Jerome

Chief Commercial Officer

C-Level
Sell9.4K$3.15$30K

Jan 2, 2025

22 months ago

Auerbach Alan H

Pres, CEO, 10%

CEO
Sell33.8K$3.15$107K

Jan 2, 2025

22 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell152.3K$-10227.00$0

Jan 2, 2025

22 months ago

Hunt Douglas M

See Remarks

Insider
Sell8.6K$3.15$27K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
PBYI Buy Conviction0%
Industry Rank#464 of 569
Volume Contribution0.0%
Total Industry Activity$16.53B

PBYI has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. PBYI ranks #464 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for PBYI

Over the last 90 days, corporate insiders at PBYI (PBYI) engaged in a total of 38 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 29 were sales. The total volume of insider trading reached $3.06M.

The net insider activity for PBYI shows a net selling bias of $3.06M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Cesano Alessandra (Dir), who traded 62.1K shares valued at $567K on Sep 14, 2026.

Live Market News & Developments
Aggregated real-time headlines for PBYI (PBYI)
6 updates

Is Puma Biotechnology (PBYI) a Great Value Stock Right Now?

Yahoo Finance100d ago

(PBYI) Risk Channels and Responsive Allocation

Stock Traders Daily2d ago

PBYI - Puma Biotechnology Inc Stock Price and Quote

Finviz176d ago

Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why

TradingView162d ago

Puma Biotechnology, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:PBYI) 2026-11-10

Seeking Alpha10d ago

Puma Biotechnology (PBYI) director Miller holds 66,000 shares directly after selling 15,000.

Stock Titan6d ago

FAQs About PBYI Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for PBYI.

Based on SEC Form 4 disclosures, the Insider Confidence Score for PBYI is currently 25/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 29 sales by company executives over the last 90 days.

The CEO Conviction Index for PBYI is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.